<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="commentaries" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JHHR</journal-id>
      <journal-title-group>
        <journal-title>Journal of Human Health Research</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2576-9383</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">JHHR-22-4138</article-id>
      <article-id pub-id-type="doi">10.14302/issn.2576-9383.jhhr-22-4138</article-id>
      <article-categories>
        <subj-group>
          <subject>commentaries</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Scientific Ethical Integrity and Human Research Subjects Protections Non-compliance Remediation: Commentary on Practical Considerations and Implications</article-title>
        <alt-title alt-title-type="running-head">remediation for human research subjects protections non-compliance: practical considerations and implications</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ralph</surname>
            <given-names>J Johnson</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842542764">1</xref>
          <xref ref-type="aff" rid="idm1842543052">2</xref>
          <xref ref-type="aff" rid="idm1842560236">*</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1842542764">
        <label>1</label>
        <addr-line>Research PA-C/Research Coordinator, University of Texas MD Anderson Cancer Center</addr-line>
      </aff>
      <aff id="idm1842543052">
        <label>2</label>
        <addr-line>Chaplain, Texas Medical Center Catholic Chaplaincy Corp.</addr-line>
      </aff>
      <aff id="idm1842560236">
        <label>*</label>
        <addr-line>Corresponding author</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Raul</surname>
            <given-names>Isea</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842410716">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1842410716">
        <label>1</label>
        <addr-line>Fundación Instituto de Estudios  Avanzados -IDEA</addr-line>
      </aff>
      <author-notes>
        <corresp>
  Ralph Jay Johnson, <addr-line>Ph.D., PA-C, M.A.H.S., M.AT. Dept. of Lymphoma/Myeloma, UT-MDACC, Unit 42, 1515 Holcombe Blvd. Houston, TX, 77030. U.S.A. 832-372-3511</addr-line><email>jayjohnson131313@gmail.com</email></corresp>
        <fn fn-type="conflict" id="idm1841806780">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2022-03-22">
        <day>22</day>
        <month>03</month>
        <year>2022</year>
      </pub-date>
      <volume>1</volume>
      <issue>3</issue>
      <fpage>24</fpage>
      <lpage>34</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>03</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>03</month>
          <year>2022</year>
        </date>
        <date date-type="online">
          <day>22</day>
          <month>03</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© </copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Ralph Jay Johnson</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org/jhhr/article/1789">This article is available from http://openaccesspub.org/jhhr/article/1789</self-uri>
      <abstract>
        <p>Medical science’s advancements depend on preserving its credibility and the public trust, though as a human institution it is fallible and               liable to ethical breaches that can void public       confidence and support. There is no more egregious ethical departure than deviations / violations of  Human Research Subjects Protections (i.e.,                   non-compliance), which is remarkable given they are fairly widespread and often repeated. Once               uncovered, this generally should result in the               research’s suspension or termination. Yet, there is a third option to preserve valuable and worthy                research that went awry due to lapses in Human Research Subjects Protections, specifically, Remediation. Due to the sequestered nature of Remediation, little has been reported on its processes, and         practically nothing, regarding practical considerations, recommendations, and    implications for the remediation workers themselves—for this line of work is perilously risky. This commentary reports some of those best-practices, “first-hand grittier               in-the-trenches” informed practical lessons learned. Implications are discussed in the interest of             improving the reasonable, balanced, and competent                    ethical conduct of research, addressing / avoiding Human Subjects Protections ethical non-compliance, and avenues for further inquiry regarding Remediation.</p>
      </abstract>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <page-count count="11"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1842407836" sec-type="intro">
      <title>Introduction</title>
      <p>Medical science is a vital and principal institution due to its promises of a far-reaching and alluring             compendium of advancements through which there is greater predictability, control, and improvement in the human condition.<xref ref-type="bibr" rid="ridm1849196052">1</xref><xref ref-type="bibr" rid="ridm1849197348">2</xref><xref ref-type="bibr" rid="ridm1849206140">3</xref> Nevertheless, it is a human                 institution—fallible, and prone to ethical breaches,             misconduct and breaks from scientific integrity.<xref ref-type="bibr" rid="ridm1849206140">3</xref><xref ref-type="bibr" rid="ridm1849263372">4</xref><xref ref-type="bibr" rid="ridm1849048332">5</xref><xref ref-type="bibr" rid="ridm1849053156">6</xref><xref ref-type="bibr" rid="ridm1849050780">7</xref> Thus, preservation of the scientific enterprise’s              credibility and the public trust vested in it is predicated on ensuring sound scientific integrity. In the post-modern era, with rapid dissemination of information and                      increased democratic processes, the risk of accusations of breaks in scientific integrity is magnified greatly.<xref ref-type="bibr" rid="ridm1849036996">9</xref><xref ref-type="bibr" rid="ridm1849041748">10</xref> The loss of public confidence in medical scientific                    research institutions may corrosively erode public                support for medical scientists and their research                  programs everywhere.<xref ref-type="bibr" rid="ridm1849206140">3</xref><xref ref-type="bibr" rid="ridm1849036996">9</xref><xref ref-type="bibr" rid="ridm1849025508">11</xref><xref ref-type="bibr" rid="ridm1849024068">12</xref> Concern should be          paramount and ubiquitous for preserving scientific               integrity and to achieve reclamation, if possible, where there have been ethical breaches in otherwise valuable and meaningful research. <xref ref-type="bibr" rid="ridm1849206140">3</xref><xref ref-type="bibr" rid="ridm1849020396">13</xref><xref ref-type="bibr" rid="ridm1849011692">14</xref><xref ref-type="bibr" rid="ridm1849009892">15</xref><xref ref-type="bibr" rid="ridm1849006148">16</xref></p>
      <p>   Probably there is no more egregious ethical breach of scientific integrity in medical research than deviations or violations (i.e., non-compliance) of Human Research               Subjects Protections, especially anything abrogating              adequate informed consent to participate in research (e.g., no consent obtained, wrong consent, language not                 translated, improperly completed consent, consent P&amp;P not followed, consent undocumented, etc.).<xref ref-type="bibr" rid="ridm1849001756">17</xref><xref ref-type="bibr" rid="ridm1848997220">18</xref><xref ref-type="bibr" rid="ridm1848986628">19</xref><xref ref-type="bibr" rid="ridm1848982812">20</xref> The integrity of Human Research Subjects Protections is                commonly considered inviolable and sacrosanct.<xref ref-type="bibr" rid="ridm1848982812">20</xref>                Unfortunately, violations are fairly common, even though there are a plethora of formally established safeguards, policies, procedures, regulations and agencies and agents, as well as punitive sanctions for such violations.<xref ref-type="bibr" rid="ridm1848978492">21</xref><xref ref-type="bibr" rid="ridm1848976764">22</xref><xref ref-type="bibr" rid="ridm1848942260">23</xref><xref ref-type="bibr" rid="ridm1848938084">24</xref><xref ref-type="bibr" rid="ridm1848949748">25</xref> A large proportion of scientific research wrongdoing (approximately 50%) falls under the rubric of Human  Research Subjects Protections non-compliance, with             nearly 100% attributable to “Failure to Follow                   Procedures.”<xref ref-type="bibr" rid="ridm1848986628">19</xref> Conservatively, there are estimates over a two-year period of about 1,200 - 2,150 cases in the U.S. per year alone.  No one can be exactly sure, because they are sensitive cases and therefore kept secret.<xref ref-type="bibr" rid="ridm1848976764">22</xref><xref ref-type="bibr" rid="ridm1848915364">27</xref>    Furthermore, most of the known offenders tend to be              repeat offenders, even with multiple layers of prevention for recidivists. <xref ref-type="bibr" rid="ridm1848947228">26</xref><xref ref-type="bibr" rid="ridm1848911260">28</xref></p>
    </sec>
    <sec id="idm1842408196">
      <title>Background</title>
      <p>Typically, after an audit finds substantial,                  continued, and patterned deviations, violations, and   abuses, an Institutional Review Board (IRB) assigns a level of non-compliance; based on this level, there are two              formal absolute options: suspension or termination.<xref ref-type="bibr" rid="ridm1848909388">29</xref><xref ref-type="bibr" rid="ridm1848907012">30</xref><xref ref-type="bibr" rid="ridm1848903052">31</xref><xref ref-type="bibr" rid="ridm1848896644">32</xref> However, there is a 3rd informal option of Remediation, depending on whether the research is valuable,     worthy, and can be redeemed through restitution and                reclamation, restoration of trust, significant risk               management, remorse and contrition, and establishing preventive plans of actions to avoid recidivism.<xref ref-type="bibr" rid="ridm1848976764">22</xref><xref ref-type="bibr" rid="ridm1848894412">33</xref><xref ref-type="bibr" rid="ridm1848889804">34</xref><xref ref-type="bibr" rid="ridm1848888652">35</xref><xref ref-type="bibr" rid="ridm1848885628">36</xref> Remediation offers scientific research institutions and agencies opportunities for reclaiming and salvaging              otherwise worthwhile research studies that went astray due Human Research Subjects Protections non-compliance.<xref ref-type="bibr" rid="ridm1849006148">16</xref><xref ref-type="bibr" rid="ridm1848976764">22</xref><xref ref-type="bibr" rid="ridm1848888652">35</xref><xref ref-type="bibr" rid="ridm1848885628">36</xref></p>
      <p>Human Research Subjects Protections                     Deviation / Violation remediation projects may be                 widespread and fairly common—so much so that IRBs employ a common acronym: “HRSPD/V-CAPA” or “CAPA” for short (i.e., Corrective And Preventive Action plan) to describe them.<xref ref-type="bibr" rid="ridm1848883180">37</xref><xref ref-type="bibr" rid="ridm1848879220">38</xref><sup>cf.39</sup> Yet, little has been written and virtually no formal research has been done on how they are conducted, much less the practical implications for those burdened with conducting them.<xref ref-type="bibr" rid="ridm1848976764">22</xref><xref ref-type="bibr" rid="ridm1848877492">39</xref><xref ref-type="bibr" rid="ridm1848873316">40</xref> Note: there are probably about as many Human Research               Subjects Protections-related CAPAs as there are scientific research-intensive institutions.<xref ref-type="bibr" rid="ridm1848869500">41</xref><xref ref-type="bibr" rid="ridm1848867196">42</xref> But any formal           reports are usually vague summaries void of practical  detail and limited to the extent IRBs require public         dissemination and demonstrations of open contrition and penitence.<xref ref-type="bibr" rid="ridm1848907012">30</xref><xref ref-type="bibr" rid="ridm1848903052">31</xref> This is probably the consequence of their embarrassing and sensitive nature, so that only            direct participants are truly privy to them.<xref ref-type="bibr" rid="ridm1849001756">17</xref><xref ref-type="bibr" rid="ridm1848997220">18</xref><xref ref-type="bibr" rid="ridm1848986628">19</xref><xref ref-type="bibr" rid="ridm1848982812">20</xref> Thus, the world of Human Research Subjects Protections             non-compliance remediation is one that is a “known            secret”—but dark, murky, nebulous and rarely discussed in public venues unless mandated, and then only to the extent mandated.<xref ref-type="bibr" rid="ridm1848976764">22</xref></p>
    </sec>
    <sec id="idm1842405244">
      <title>Purpose</title>
      <p>A substantial number of Human Research                Subjects Protections CAPAs also are a testament to the notion that valuable scientific research studies can and do make related mistakes, but these can be redeemed through remediation. <xref ref-type="bibr" rid="ridm1849206140">3</xref><xref ref-type="bibr" rid="ridm1849020396">13</xref><xref ref-type="bibr" rid="ridm1849011692">14</xref><xref ref-type="bibr" rid="ridm1849009892">15</xref><xref ref-type="bibr" rid="ridm1849006148">16</xref><xref ref-type="bibr" rid="ridm1848976764">22</xref> Yet, formal empirical studies on Human Research Subjects Protections                      violation remediation would be an admission that an  egregious, non-condoned, profane violation occurred of something considered sanctified. “It is not supposed to happen, but it does, and how it is done and what does that mean for the one(s) who have to do it has been as-of-yet unspoken.”<xref ref-type="bibr" rid="ridm1848834804">43</xref><xref ref-type="bibr" rid="ridm1848829836">44</xref> Nevertheless, given that these affairs and their repair are apparently widespread, and to fill the gap regarding this vital information, the purpose of this article is to provide some informed conceptual yet                   practical lessons learned on involvement with Human    Research Subjects Protections non-compliance                    remediation projects—particularly from the perspective and best interests of those directly involved with them. The points derive from the author’s first-hand experience with repairing, reclaiming, and resurrecting multiple                errant research studies that were temporarily suspended due to Human Research Subjects Protections deviations and violations at multiple research-intensive institutions. Though the perspective is that of an outsider or distanced party brought-in and  specifically tasked with fixing up, cleaning up and restoring a study or studies to ethical health, the advice, guidance, and recommendations are just as relevant to insiders involved with Human                    Research Subjects Protections Violation remediation.</p>
    </sec>
    <sec id="idm1842405820" sec-type="conclusions">
      <title>Commentary</title>
      <p>First, Human Research Subjects Protections                 Violation remediation projects can be extremely                       expensive and labor-intensive, as they probably will                   involve painstakingly re-conducting work that was done wrong or not at all for substantial numbers of human              research subjects (e.g., hundreds, if not in the thousands).<xref ref-type="bibr" rid="ridm1848826524">45</xref> “Remediation is a third option, but it is no free pass.”<xref ref-type="bibr" rid="ridm1848976764">22</xref> Also, remediation projects tend to be painful, ugly, and even dreadful affairs in that they involve an                admission of extreme wrongdoing regarding a subject that should be sacrosanct— the defilement of which              definitely is in the realm of professional discretization. So finger-pointing, “backbiting,” and recriminations are not unusual—not to mention concerns about that ‘the                 competitors in a highly competitive field might take the information and run with it should it leak out and become public.’ The best possible course of action to counter all this is quickly: ‘To get it out, you get it out, and you take control.’<xref ref-type="bibr" rid="ridm1848825732">46</xref> Taking control involves transitioning quickly to acceptance of what happened, an accurate and visual needs assessment of the extent of wrongdoing, and the fast development of a course of action to correct it—and then implementing the plan as quickly and with as little fanfare as possible.<xref ref-type="bibr" rid="ridm1848976764">22</xref><xref ref-type="bibr" rid="ridm1848825732">46</xref> Also, it is better to propose a workable resolution developed from accurate data to the IRB and/or other regulatory agencies rather than have them propose an uniform one that is unworkable. Doing so also demonstrates control, competence, and                  subject-matter expertise regarding the situation, which can work wonders to restore trust and credibility. </p>
      <p>Second, cleaning up and fixing up a mess often involves getting one’s hands dirty. Specifically, there may be “guilt by association.”<xref ref-type="bibr" rid="ridm1848821484">47</xref> That is, the person or                 persons charged with remediation may become errantly typecast in the public eye—somewhere between                       ultimately responsible for the mess in the first place, or associated with hard feelings surrounding the project  itself (or both). Often, when Human Research Subjects Protections non-compliance is revealed—and especially where there was a substantial, longstanding pattern of behavior—the culprits responsible may attempt to run away, hide, and feign ignorance. Specifically, they turn tail and run knowing the true extent of the mess they created when faced with the unappealing and laborious prospect of cleaning-and-fixing-up a big mess with repercussions that may taint their reputations and careers. Moreover, anyone tasked with a remediation project should be cognizant that those involved in the non-compliance may use the self-serving and treacherous yet clever ruse of implying those involved in the remediation effort must have caused the non-compliance in the first place—or else they would not be involved in the remediation. This is not to mention that those privy to what resulted in the                  misconduct probably will be unavailable to those              cleaning-up the resulting mess, so the Remediation Team will not have the benefit of their insight and knowledge to inform reclamation efforts. </p>
      <p>Again, these situations have the potential to       become rife with finger-pointing and blame-laying,                    especially at the innocent feet of the remediation               workers. A viable recommended strategy for the                remediation crew to counter the implications of “guilt by association” is to emphatically and publicly insist they were not the parties causing the original                                  non-compliance with Human Research Subjects                    Protections; they are charged with helping to formulate and implement a viable solution. Vigorous support from research institutions’ regulators and administrators of these public relations efforts should be obtained in              advance of a remediation assignment.</p>
      <p>Third, given the seriousness of allegations by the IRB or regulatory agencies, it is always a good idea to conduct a parallel internal investigation of the breadth and depth of external probes and findings (i.e., a needs assessment).<xref ref-type="bibr" rid="ridm1848976764">22</xref> In other words, auditor / regulator reports should not be relied on exclusively. Typically, they only represent a sampling of detectable, significant Human Research Subjects Protections non-compliance, which might merely scratch the surface and fail to delve extensively into the problems.<xref ref-type="bibr" rid="ridm1848976764">22</xref><xref ref-type="bibr" rid="ridm1848896644">32</xref><xref ref-type="bibr" rid="ridm1848883180">37</xref><xref ref-type="bibr" rid="ridm1848879220">38</xref><xref ref-type="bibr" rid="ridm1848834804">43</xref>                Naturally, once detected in substantial and patterned amounts, formulations of systematic remediation plans should be predicated on a comprehensive needs                  assessment survey.<xref ref-type="bibr" rid="ridm1848976764">22</xref> This survey should be conducted to visually depict any patterns and connections and to keep all parties focused and honest. This survey should be reported to the IRB.<xref ref-type="bibr" rid="ridm1848976764">22</xref> This will facilitate a more hands-on, practical apprehension of what happened, how it happened, and how it can be fixed and improved or prevented going forward.<xref ref-type="bibr" rid="ridm1848877492">39</xref><xref ref-type="bibr" rid="ridm1848825732">46</xref><xref ref-type="bibr" rid="ridm1848815220">48</xref> Also, it will help prevent the remediation team from cutting corners in the interest of expediency. </p>
      <p>Most likely, one reason significant problems            occurred in the first place was that no routine internal audit mechanism was established—or, if there was one, it was not comprehensive or involved enough. An internal needs assessment is the opportunity to  establish a                 routine audit mechanism. A comprehensive survey                entails a replete inventory and description of particular types and amounts of non-compliance. These are the “what happened” factors related to the unmet Human Research Subjects Protections regulatory standards; these types of problems can be ranked in terms of amounts and severity and the aggravating circumstances of whether they were unintentional or willful.<xref ref-type="bibr" rid="ridm1848976764">22</xref>                  Addressing each issue then can become a collaboration between the IRB, regulatory agencies and study             investigators. Doing so comprehensively and                           systematically can be a great confidence restorer by showing that the remediation workers are ethically “true to their word.”</p>
      <p>Fourth, remediation workers should be keenly aware that they are involved in the airing and cleaning of dirty laundry. In an industry that emphasizes image and professional reputation and prides itself on adherence and compliance with best-practices standards, there may be fears that the workers might talk.<xref ref-type="bibr" rid="ridm1849050780">7</xref><xref ref-type="bibr" rid="ridm1848873316">40</xref> Remediation projects necessarily have deadlines for completion                 imposed by IRBs. When the work is over, there is an                intrinsic risk—rather than gratitude for the Herculean tasks and egregious conditions under which they were accomplished—that the remediation workers may be           disposed of over contrived reasons, much like sweeping yesterday’s dirt under the rug with prejudice.<xref ref-type="bibr" rid="ridm1848814140">49</xref> Any  protests they register will be met with counter-protests of “sour grapes.”<xref ref-type="bibr" rid="ridm1848814140">49</xref> Likewise, public awards and tokens of appreciation for their hard work and a job well done will probably not be forthcoming, because this would be a             formal acknowledgement that something sordid and             scandalous occurred, which would rather be buried and forgotten.<xref ref-type="bibr" rid="ridm1848814140">49</xref> Also, study administrators and investigators may want to be rid of constant haunting reminders of past transgressions. The remediation work may just be over with anyway.<xref ref-type="bibr" rid="ridm1848814140">49</xref> One way to allay these fears would be for remediation workers to sign self-imposed                             non-disclosure agreements to secure their employment and ensure their discretion. </p>
      <p>In sum, the interest of furthering the discourse on scientific integrity, this article attempted to provide some practical cautionary considerations and recommendations regarding involvement in Human Research Subjects               Protections Violation remediation and reclamation                projects for those “in the trenches.” In terms of the                   consequences of considerations and aspects of Human                       Research Subjects Protections Violation remediation, this article proposes a practical, gritty real-world in-the-trenches depiction of scientific research ethics that can be synthesized and summarized as the following: “In the end, doing the right thing because it is the right thing to do will probably hurt,” or, “No good deed has ever gone                        unpunished.” But one still does the right thing anyway so as to look oneself in the mirror in the morning.</p>
      <p>Rather than just a guidebook for side-stepping potential landmines, this article also tacitly highlighted that the pristine, ideal environment in which Human                Subjects Protections are expected to be kept, the                  substantial efforts, personnel and resources expended to do so, and the absolutist sanctions for failing to do so, have seemingly established a Zero-Defect culture around an enterprise in which human error is the norm rather than the exception.<xref ref-type="bibr" rid="ridm1848947228">26</xref><xref ref-type="bibr" rid="ridm1848841284">50</xref> A Zero-Defect culture<xref ref-type="bibr" rid="ridm1848838404">51</xref>                dictates that such standards are so sacrosanct and              inviolable that the research intensive institution and its personnel could not possibly engage in their violation or even deviation—whether this is actually true or not. A  Zero-Defect culture, which is commonly considered               ineffective, exists where the administration is intolerant of any errors, deviations or violations; it may choose to                ignore evidence of any kind. As such, workers are not held accountable or empowered by failures and become               complacent and unmotivated.<xref ref-type="bibr" rid="ridm1848838404">51</xref> As such, in this culture workers who identify and report and fix mistakes (i.e., “stop-the-line”) tend to be held in contempt and public opprobrium, even if they were not the source of the               mistakes.<xref ref-type="bibr" rid="ridm1848814140">49</xref></p>
      <p> This can be synergistically compounded by a            scientific research culture of Paternalism.<xref ref-type="bibr" rid="ridm1848841284">50</xref><xref ref-type="bibr" rid="ridm1848838404">51</xref><sup>61</sup><sup>62</sup><sup>63</sup><sup>64</sup><sup>65</sup><sup>66</sup><sup>67</sup><sup>68</sup><sup>69</sup><sup>70</sup><sup>71</sup> Specifically, this is where renowned and funded medical researchers maintain a notion that they hold high                authority due to their subject matter expertise in a                  particularly complicated and technical discipline; this tempts them to involuntarily or volitionally conduct                 research for their own interests and/or the greater good of science rather than in their patients’ interests—because their patients “could never understand.” The two cultures together and unchecked can synergistically result in a           perfect storm that spawns substantial hidden Human                Research Subject non-compliance, until some unexpected event causes them to surface.<xref ref-type="bibr" rid="ridm1848814140">49</xref><xref ref-type="bibr" rid="ridm1848947228">26</xref></p>
      <p>This destructive pattern can be countered by a commitment to a: (1) Participatory Study approach to             engaging patients where they are treated less as research subjects and more as participants in a collaborative effort <xref ref-type="bibr" rid="ridm1848835740">52</xref><xref ref-type="bibr" rid="ridm1848781804">53</xref><xref ref-type="bibr" rid="ridm1848781300">54</xref><xref ref-type="bibr" rid="ridm1848777052">55</xref><xref ref-type="bibr" rid="ridm1848947228">26</xref>; and (2) a Culture of Safety that acknowledges, though mistakes and errors should be avoided, that               mistakes and errors do happen as we are all                                human.<xref ref-type="bibr" rid="ridm1848774604">56</xref><xref ref-type="bibr" rid="ridm1848772228">57</xref><xref ref-type="bibr" rid="ridm1848767116">58</xref> Both (1) and (2) together mean that (1) actively engaged Study Participants have much to teach researchers and (2) admission and study of ethical                  mistakes can be learning experiences from which to       enhance adherence to policy and procedures and foster        innovation from lessons learned. This combined approach has the additional benefit of workers and administrators taking responsibility and accountability for their actions, thus anyone can “stop-the-line,” if they realize things have gone awry. </p>
    </sec>
    <sec id="idm1842404308" sec-type="conclusions">
      <title>Conclusion</title>
      <p>At heart this article is a stark admission that there is an unavoidable professional commitment to                 ensure that scientific research is conducted both ethically and competently; but failing that, remediation cannot    entirely fix and make it like new again. Remediation can resurrect studies but cannot turn back the clock as if any wrongdoing or errors never happened. Nevertheless,    remediation may be the one saving grace to reclaim                  valuable and important research despite Human Research Subjects Protections non-compliance. To fill a gap in the scientific integrity and ethics literature regarding                 information about the personal risks and hazards of those in the “remediation trenches,” this article provided             pointers with practical implications along with                          recommendations of best practices. </p>
      <p>At minimum, this article acknowledges a known problem that has been kept in the shadows due to its                sensitive, controversial, and taboo nature. At best, this  article serves as the impetus for more definitive and               perhaps empirical works and discourses on the subject matter. Then the hushed whispers and disquietude                 surrounding a heretofore forbidden and censured subject will be brought to light and transformed into acceptable and credible peer-reviewed scientific articles. After all, prevention is far less costly than cure, and the focus should be on preventing scientific misconduct and ethical              breaches, especially Human Subjects Protections                    non-compliance, rather than fixing and cleaning up the damage afterward. Yet, without a common body of knowledge about Human Subjects Protection Violations / Deviations and their corrective remediation, this less              costly prevention is improbable.</p>
    </sec>
    <sec id="idm1842340268">
      <title>Declarations</title>
      <sec id="idm1842340340">
        <title>Ethical Approval and Consent to Participate</title>
        <p>Non-applicable, this was a commentary supported by a review of supporting open-source documents and analyses of anonymous publically available data.</p>
      </sec>
      <sec id="idm1842339332">
        <title>Consent for Publication</title>
        <p>Yes.</p>
      </sec>
      <sec id="idm1842340628">
        <title>Availability of Data and Materials</title>
        <p>Yes, publications and sources are available on-line or provided by author upon request.</p>
      </sec>
    </sec>
    <sec id="idm1842338540">
      <title>Funding</title>
      <p>This project was supported by in-kind support from the University of Texas MD Anderson Cancer Center, Dept. of Myeloma-Lymphoma, which the author gratefully acknowledges.</p>
    </sec>
    <sec id="idm1842338108">
      <title>Authors’ Contribution</title>
      <p>Non-applicable, there is one sole Author.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The Author wishes to gratefully acknowledge in-kind support of the Department of Lymphoma and Myeloma, UT-MD Anderson Cancer Center, Houston, TX. in the preparation of this manuscript. Also, the author thanks Mr. Jasper Olsem for his encouragement in pursuing the subject matter. The author also expresses appreciation for Michael P. Ramos for proof of concept, and Ms. Aileen “Acey” Cho freelance-copy editor for proofing and copyediting drafts. The opinions expressed are solely those of the Author. Reprints and correspondence should be addressed to the author at <ext-link xlink:href="mailto:ralph.johnson@txsg.state.tx.us" ext-link-type="uri">ralph.johnson@txsg.state.tx.us</ext-link>, <ext-link xlink:href="mailto:rjjohnson@mdanderson.org" ext-link-type="uri">rjjohnson@mdanderson.org</ext-link>, or, <ext-link xlink:href="mailto:jayjohnson131313@gmail.com" ext-link-type="uri">jayjohnson131313@gmail.com</ext-link> UT-MDACC, Dept. of Lymphoma-Myeloma, Unit 429, 1515 Holcombe, Houston, Texas, 77030-400, U.S.A.. (832-750-1446; 832-372-3511)</p>
    </ack>
    <ref-list>
      <ref id="ridm1849196052">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Weisberg</surname>
            <given-names>D F</given-names>
          </name>
          <article-title>Science in the Service of Patients: Lessons from the Past in the Moral Battle for the Future of Medical Education</article-title>
          <date>
            <year>2014</year>
          </date>
          <source>Yale J Biol Med. Mar;</source>
          <volume>87</volume>
          <issue>1</issue>
          <fpage>79</fpage>
          <lpage>89</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849197348">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Staman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dijstelbloem</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Smits</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Afterword inReshaping the Human Condition: Exploring Human Enhancement(eds.) Leo Zonneveld</article-title>
          <date>
            <year>2008</year>
          </date>
          <chapter-title>Huub Dijstelbloem &amp; Danielle Ringoir Rathenau Institute, The Hague 2008: 149 –</chapter-title>
          <fpage>160</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849206140">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Koepsell</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Scientific Integrity and Research Ethics: An Approach from the Ethos of Science: Springer Briefs in Ethics</article-title>
          <date>
            <year>2015</year>
          </date>
          <fpage>1</fpage>
          <lpage>50</lpage>
          <publisher-name>Springer Nature: International</publisher-name>
          <publisher-loc>Cham, Switzerland:</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1849263372">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <article-title>Academy of Sciences, and National Academy of Engineering. (1995)On Being a Scientist: Responsible Conduct</article-title>
          <chapter-title>in Research, Second Edition. Washington, DC: The National Academies Press. https://doi.org/10.17226/4917:</chapter-title>
          <fpage>15</fpage>
          <lpage>16</lpage>
          <institution>Institute of Medicine, National</institution>
        </mixed-citation>
      </ref>
      <ref id="ridm1849048332">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <source>GUIDELINES FOR RESEARCH ETHICS IN THE SOCIAL SCIENCES, LAW AND THE HUMANITIES</source>
        </mixed-citation>
      </ref>
      <ref id="ridm1849053156">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Honig</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lampel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Baum</surname>
            <given-names>J A</given-names>
          </name>
          <name>
            <surname>Glynn</surname>
            <given-names>M A</given-names>
          </name>
          <article-title>Reflections on Scientific Misconduct in Management: unfortunate incidents or a normative crisis?Academy of Management Perspectives32,(4).https://doi.org/10.5465/amp.2015.0167</article-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1849050780">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>CLS</surname>
            <given-names>Veldkamp</given-names>
          </name>
          <name>
            <surname>CHJ</surname>
            <given-names>Hartgerink</given-names>
          </name>
          <name>
            <surname>van</surname>
            <given-names>Assen MALM</given-names>
          </name>
          <name>
            <surname>Wicherts</surname>
            <given-names>J M</given-names>
          </name>
          <date>
            <year>2017</year>
          </date>
          <chapter-title>Who believes in the Storybook image of the scientist?Account Res:</chapter-title>
          <volume>24</volume>
          <issue>3</issue>
          <fpage>127</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="doi">10.1080/08989621.2016.1268922</pub-id>
          <pub-id pub-id-type="pmid">28001440</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1849038220">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <article-title>National Academies of Sciences, Engineering, and Medicine; Policy and Global Affairs; Committee on Science, Engineering, Medicine, and Public Policy; Committee on Responsible Science. Foundations of integrity in research: Core values and guiding norms inFostering Integrity in Research: ashington (DC): National Academies Press (US);</article-title>
          <date>
            <year>2017</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1849036996">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>THE</surname>
            <given-names>WHITE HOUSE</given-names>
          </name>
          <article-title>Memorandum on Restoring Trust in Government Through Scientific Integrity and Evidence-Based Policymaking.Executive Order: Jan 27;</article-title>
          <date>
            <year>2021</year>
          </date>
          <publisher-loc>Washington, D.C</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1849041748">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <article-title>the Bipartisan Policy Center’s Science for Policy Project. (2009).Improving the Use of Science in Regulatory Policy: Final Report. Science for PolicyProject: Aug 5: 41-45 and 49</article-title>
          <source/>
          <volume>51</volume>
          <institution>Members of</institution>
        </mixed-citation>
      </ref>
      <ref id="ridm1849025508">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Funk</surname>
            <given-names>C</given-names>
          </name>
          <article-title>findings about Americans’ confidence in science and their views on scientists’ role in society.Pew Research Center: Feb 12:</article-title>
          <date>
            <year>2020</year>
          </date>
          <publisher-loc>Washington, D.C</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1849024068">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Anderson</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rainie</surname>
            <given-names>L</given-names>
          </name>
          <chapter-title>(2017)The Future of Truth and Misinformation Online. . Pew Research</chapter-title>
          <publisher-loc>Center: Washington, D.C</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1849020396">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>National</surname>
            <given-names>Research Council</given-names>
          </name>
          <article-title>and Institute of Medicine (US) Committee on Assessing Integrity in Research Environments. (2002)Integrity in Researchin Integrity in Scientific Research: Creating an Environment That Promotes Responsible Conduct. Washington (DC):</article-title>
          <publisher-name>National Academies Press (US)</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="ridm1849011692">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Lenzer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hoffman</surname>
            <given-names>J R</given-names>
          </name>
          <name>
            <surname>Furberg</surname>
            <given-names>C D</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>J P</given-names>
          </name>
          <article-title>Guideline Panel Review Working Group. Ensuring the integrity of clinical practice guidelines: a tool for protecting patients.BMJ.347:</article-title>
          <date>
            <year>2013</year>
          </date>
          <fpage>5535</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1136/bmj.f5535</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1849009892">
        <label>15.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Antes</surname>
            <given-names>A L</given-names>
          </name>
          <name>
            <surname>Maggi</surname>
            <given-names>Jr LB</given-names>
          </name>
          <article-title>How to conduct responsible research: A guide for graduate students.CurrProtoc:</article-title>
          <date>
            <year>2021</year>
          </date>
          <chapter-title>Mar;1(3):e87. doi: 10.1002/cpz1.87. PMID: 33740292 PMCID: PMC8277481</chapter-title>
          <pub-id pub-id-type="doi">10.1002/cpz1.87</pub-id>
          <pub-id pub-id-type="pmid">33740292</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1849006148">
        <label>16.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Angelos</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>T F</given-names>
          </name>
          <name>
            <surname>Sampson</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hollings</surname>
            <given-names>D D</given-names>
          </name>
          <article-title>Informed consent, capitation, and conflicts of interest in clinical trials: views from the field</article-title>
          <date>
            <year>2006</year>
          </date>
          <source>Surgery: Nov;</source>
          <volume>140</volume>
          <issue>5</issue>
          <fpage>740</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.surg.2006.06.027</pub-id>
          <pub-id pub-id-type="pmid">17084716https://linkinghub.elsevier.com/retrieve/pii/S0039-6060(06)00473-9</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1849001756">
        <label>17.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Koepsell</surname>
            <given-names>D</given-names>
          </name>
          <date>
            <year>2015</year>
          </date>
          <chapter-title>Scientific Integrity and Research Ethics:</chapter-title>
          <fpage>73</fpage>
          <lpage>83</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848997220">
        <label>18.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>DuBois</surname>
            <given-names>J M</given-names>
          </name>
          <name>
            <surname>Anderson</surname>
            <given-names>E E</given-names>
          </name>
          <name>
            <surname>Chibnall</surname>
            <given-names>J T</given-names>
          </name>
          <name>
            <surname>Diakov</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Preventing Egregious Ethical Violations in Medical Practice: Evidence-Informed Recommendations from a Multidisciplinary Working Group</article-title>
          <date>
            <year>2018</year>
          </date>
          <source>J MedRegul: Dec;</source>
          <volume>104</volume>
          <issue>4</issue>
          <fpage>23</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.30770/2572-1852-104.4.23</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1848986628">
        <label>19.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>DuBois</surname>
            <given-names>J M</given-names>
          </name>
          <name>
            <surname>Anderson</surname>
            <given-names>Emily E</given-names>
          </name>
          <name>
            <surname>Chibnall</surname>
            <given-names>J T</given-names>
          </name>
          <name>
            <surname>Mozersky</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Serious Ethical Violations in Medicine: A Statistical and Ethical Analysis of 280 Cases in the United States from 2008-2016.Am JBioeth</article-title>
          <date>
            <year>2019</year>
          </date>
          <volume>19</volume>
          <issue>1</issue>
          <fpage>16</fpage>
          <lpage>34</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848982812">
        <label>20.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>BAC</surname>
            <given-names>Moreno</given-names>
          </name>
          <name>
            <surname>Arteaga</surname>
            <given-names>GMII G</given-names>
          </name>
          <article-title>Violation of ethical principles in clinical research. Influences and possible solutions for Latin America.BMC Med Ethics</article-title>
          <date>
            <year>2012</year>
          </date>
          <fpage>13</fpage>
          <lpage>35</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848978492">
        <label>21.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>WhiteMG</surname>
            <given-names/>
          </name>
          <article-title>Why Human Subjects Research Protection Is Important.Ochsner</article-title>
          <date>
            <year>2020</year>
          </date>
          <source>J. Spring;</source>
          <volume>20</volume>
          <issue>1</issue>
          <fpage>16</fpage>
          <lpage>33</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848976764">
        <label>22.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Johnson</surname>
            <given-names>R J</given-names>
          </name>
          <article-title>Remediation for Human Research Subjects Protections Non-Compliance:</article-title>
          <date>
            <year>2015</year>
          </date>
          <source>Concepts and Approaches.Clinical Research &amp; Bioethics.J Clinic ResBioeth</source>
          <volume>6</volume>
          <issue>3</issue>
          <fpage>1</fpage>
          <lpage>10</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848942260">
        <label>23.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Chubin</surname>
            <given-names>D E</given-names>
          </name>
          <date>
            <year>1985</year>
          </date>
          <source>Research malpractice.BioScience</source>
          <volume>35</volume>
          <issue>2</issue>
          <fpage>80</fpage>
          <lpage>89</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848938084">
        <label>24.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Dingell</surname>
            <given-names>J D</given-names>
          </name>
          <article-title>Shattuck Lecture--misconduct in medical research.NEnglJ Med:</article-title>
          <date>
            <year>1993</year>
          </date>
          <volume>328</volume>
          <issue>22</issue>
          <fpage>1610</fpage>
          <lpage>5</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848949748">
        <label>25.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Burke</surname>
            <given-names>D L</given-names>
          </name>
          <article-title>Research misconduct: deviance, due process, and the disestablishment of science.GM</article-title>
          <date>
            <year>1995</year>
          </date>
          <source>Ind L Rev</source>
          <volume>3</volume>
          <fpage>305</fpage>
          <lpage>315</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848947228">
        <label>26.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Dubois</surname>
            <given-names>J M</given-names>
          </name>
          <name>
            <surname>Carroll</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gibb</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kraus</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Environmental Factors Contributing to Wrongdoing in Medicine:</article-title>
          <date>
            <year>2012</year>
          </date>
          <source>A Criterion-Based Review of Studies and Cases.EthicsBehav;</source>
          <chapter-title>Epub</chapter-title>
          <volume>22</volume>
          <issue>3</issue>
          <fpage>163</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="doi">10.1080/10508422.2011.641832</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1848915364">
        <label>27.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Marshall</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Scientific misconduct. How prevalent is fraud? That&amp;apos;s a million-dollar question.Science:</article-title>
          <date>
            <year>2000</year>
          </date>
          <volume>290</volume>
          <issue>5497</issue>
          <fpage>1662</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1126/science.290.5497.1662</pub-id>
          <pub-id pub-id-type="pmid">11186377</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1848911260">
        <label>28.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Fanelli</surname>
            <given-names>D</given-names>
          </name>
          <article-title>How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data.PLoSOne;</article-title>
          <date>
            <year>2009</year>
          </date>
          <volume>4</volume>
          <issue>5</issue>
          <fpage>5738</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848909388">
        <label>29.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Grant</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Alfred</surname>
            <given-names>K C</given-names>
          </name>
          <article-title>Sanctions and recidivism: an evaluation of physician discipline by state medical boards.J Health Polit Policy Law</article-title>
          <date>
            <year>2007</year>
          </date>
          <volume>32</volume>
          <issue>5</issue>
          <fpage>867</fpage>
          <lpage>85</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848907012">
        <label>30.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Bankert</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Amdur</surname>
            <given-names>R J</given-names>
          </name>
          <article-title>Institutional Review Board: Management and Function: Management and Function 2nd Edition: Jones and Bartlett Publishers; Sudsbury</article-title>
          <date>
            <year>2010</year>
          </date>
          <fpage>85</fpage>
          <lpage>13</lpage>
          <publisher-loc>MA:</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1848903052">
        <label>31.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <article-title>Ethics and compliance plan. Report to the Compliance and Audit Committee of the Board of Regents</article-title>
          <date>
            <year>2009</year>
          </date>
          <institution>University of California</institution>
        </mixed-citation>
      </ref>
      <ref id="ridm1848896644">
        <label>32.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Bhatt</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Protocol deviation and violation.PerspectClin Res</article-title>
          <date>
            <year>2012</year>
          </date>
          <volume>3</volume>
          <issue>3</issue>
          <fpage>117</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848894412">
        <label>33.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>CDC</surname>
            <given-names/>
          </name>
          <article-title>Human Subjects Research Protection. Policy Science Administration</article-title>
          <date>
            <year>2010</year>
          </date>
          <publisher-loc>CDC-SA.https://www.cdc.gov/os/integrity/docs/cdc-policy-human-research-protections.pdf</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1848889804">
        <label>34.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Borysov</surname>
            <given-names>Antoniuk OI</given-names>
          </name>
          <name>
            <surname>Pashchenko</surname>
            <given-names>O O</given-names>
          </name>
          <article-title>Peculiarities of legal responsibility for offenses in the field of clinical trials of medicines.WiadLek:</article-title>
          <date>
            <year>2020</year>
          </date>
          <volume>73</volume>
          <issue>12</issue>
          <fpage>2833</fpage>
          <lpage>2839</lpage>
          <pub-id pub-id-type="pmid">33611290https://pubmed.ncbi.nlm.nih.gov/33611290/</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1848888652">
        <label>35.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Antkowiak</surname>
            <given-names>T M</given-names>
          </name>
          <name>
            <surname>Colum</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Transnat&amp;apos;l</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Remedial approaches to human rights violations: The Inter-American Court of human rights and beyond.J.Transnat&amp;apos;lL</article-title>
          <date>
            <year>2007</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1848885628">
        <label>36.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Cohen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Adashi</surname>
            <given-names>E Y</given-names>
          </name>
          <date>
            <year>2012</year>
          </date>
          <chapter-title>In the Wake of Guatemala: The Case for Voluntary Compensation and Remediation.AJPH: 102</chapter-title>
          <fpage>4</fpage>
          <lpage>6</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848883180">
        <label>37.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Pereira</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Quality in clinical research activities: Role of institution/clinical trial site</article-title>
          <source>JNABoardHospitals &amp; HealthcareProviders(2</source>
          <volume>1</volume>
          <publisher-name>January-June</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="ridm1848879220">
        <label>38.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Bramstedt</surname>
            <given-names>K A</given-names>
          </name>
          <article-title>A study of warning letters issued to clinical investigators by the United States Food and Drug Administration.Clin Invest Med:</article-title>
          <date>
            <year>2004</year>
          </date>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>129</fpage>
          <lpage>34</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848877492">
        <label>39.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Mehra</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kurpanek</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Petrizzo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brenner</surname>
            <given-names>S</given-names>
          </name>
          <article-title>The life cycle and management of protocol deviations.TherInn</article-title>
          <date>
            <year>2014</year>
          </date>
          <source>Reg Sci</source>
          <volume>48</volume>
          <fpage>762</fpage>
          <lpage>77730</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848873316">
        <label>40.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Benoit</surname>
            <given-names>W L</given-names>
          </name>
          <article-title>Image repair discourse and crisis communication.Public Relations ReviewVolume 23, Issue 2, Summer</article-title>
          <date>
            <year>1997</year>
          </date>
          <fpage>177</fpage>
          <lpage>186</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848869500">
        <label>41.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Robitaille</surname>
            <given-names>D E</given-names>
          </name>
          <article-title>(2011)The Corrective Action Handbook</article-title>
          <date>
            <year/>
          </date>
          <publisher-name>Paton Professional Press;</publisher-name>
          <publisher-loc>Chico, CA</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1848867196">
        <label>42.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Massett</surname>
            <given-names>H A</given-names>
          </name>
          <name>
            <surname>Mishkin</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Rubinstein</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ivy</surname>
            <given-names>S P</given-names>
          </name>
          <article-title>(2016)Challenges facing Early Phase Trials sponsored by the National Cancer Institute: An analysis ofCorrective Action Plans to improve accrual.5408-5416</article-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1848834804">
        <label>43.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Manuele</surname>
            <given-names>F A</given-names>
          </name>
          <article-title>Incident investigation: Our methods are flawed.Prof</article-title>
          <date>
            <year>2014</year>
          </date>
          <source>SafetyJ</source>
          <volume>59</volume>
          <issue>10</issue>
          <fpage>34</fpage>
          <lpage>43</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848829836">
        <label>44.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>He</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>While it is not deliberate, much of today&amp;apos;s biomedical research contains logical and technical flaws, showing a need for corrective action.Int J Med Sci</article-title>
          <date>
            <year>2018</year>
          </date>
          <volume>15</volume>
          <issue>4</issue>
          <fpage>309</fpage>
          <lpage>322</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848826524">
        <label>45.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Rettig</surname><given-names>R A</given-names></name><article-title>The industrialization of clinical research.HEALTH</article-title><date><year>2000</year></date>
AFFAIRS: https://doi.org/10.1377/hlthaff.19.2.129



</mixed-citation>
      </ref>
      <ref id="ridm1848825732">
        <label>46.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Raddi</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Deveriniti</surname>
            <given-names>R S</given-names>
          </name>
          <name>
            <surname>Ganachari</surname>
            <given-names>G S</given-names>
          </name>
          <article-title>A retrospective study: root cause analysis of reported serious adverse event and development of corrective action and preventive action for deviated serious adverse event reports at a clinical trial site management office.Int</article-title>
          <date>
            <year>2020</year>
          </date>
          <source>J ClinTrials:</source>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>194</fpage>
          <lpage>199</lpage>
          <publisher-name>DOI:</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="ridm1848821484">
        <label>47.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Hussingerab</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Pellens</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Guilt by association: How scientific misconduct harms prior collaborators</article-title>
          <date>
            <year>2019</year>
          </date>
          <source>Research Policy:</source>
          <volume>48</volume>
          <issue>2</issue>
          <fpage>516</fpage>
          <lpage>530</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848815220">
        <label>48.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Roach</surname>
            <given-names>J D</given-names>
          </name>
          <article-title>Quality Oversight in nursing research (Ch 6) inBuilding and Sustaining a Hospital-Based Nursing ResearchProgram:</article-title>
          <date>
            <year>2016</year>
          </date>
          <fpage>123</fpage>
          <lpage>150</lpage>
          <publisher-name>Springer Publishing; NY</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="ridm1848814140">
        <label>49.</label>
        <mixed-citation xlink:type="simple" publication-type="book"><name><surname>Miethe</surname><given-names>T D</given-names></name><article-title>Individual and organizational consequences of whistleblowing inWhistleblowing at Work: Tough Choices</article-title><date><year>1999</year></date><chapter-title>in Exposing Fraud, Waste, and Abuse on the Job</chapter-title><fpage>53</fpage><lpage>75</lpage><publisher-loc>Routledge: NY, NY</publisher-loc>
eBook ISBN 9780429267512https://doi.org/10.4324/9780429267512



</mixed-citation>
      </ref>
      <ref id="ridm1848841284">
        <label>50.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Steele</surname><given-names>J P</given-names></name><article-title>Antecedents and Consequences of Toxic Leadership in the U. S. Army: A Two Year Review and Recommended Solutions</article-title><date><year>2011</year></date>
Technical rept.https://apps.dtic.mil/sti/citations/ADA545383



</mixed-citation>
      </ref>
      <ref id="ridm1848838404">
        <label>51.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Deming</surname>
            <given-names>W E</given-names>
          </name>
          <article-title>Transformation of Western Style of Management</article-title>
          <date>
            <year>1985</year>
          </date>
          <source>INFORMS Journal on Applied Analytics:</source>
          <fpage>1</fpage>
          <lpage>146</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848835740">
        <label>52.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Miller</surname>
            <given-names>F G</given-names>
          </name>
          <name>
            <surname>Wertheimer</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Facing up to paternalism in research ethics.The Hastings Center Report:</article-title>
          <date>
            <year>2007</year>
          </date>
          <volume>37</volume>
          <issue>3</issue>
          <fpage>24</fpage>
          <lpage>34</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848781804">
        <label>53.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Reilly</surname><given-names>R C</given-names></name><article-title>Participatory case study</article-title><date><year>2010</year></date><fpage>658</fpage><lpage>660</lpage>
In: Mills, Albert J. and Durepos, Gabrielle and Wiebe, Elden, (eds.)Encyclopedia of case study research. Sage, Thousand Oaks, CA



</mixed-citation>
      </ref>
      <ref id="ridm1848781300">
        <label>54.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Hudon</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chouinard</surname>
            <given-names>M-C</given-names>
          </name>
          <name>
            <surname>Bisson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Danish</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Karam</surname>
            <given-names>Marlène</given-names>
          </name>
          <article-title>Case study with a participatory approach: Rethinking pragmatics of stakeholder engagement for implementation research.Ann Fam Med:</article-title>
          <date>
            <year>2021</year>
          </date>
          <source>Nov-Dec</source>
          <volume>19</volume>
          <issue>6</issue>
          <fpage>540</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="doi">10.1370/afm.2717</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1848777052">
        <label>55.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Wright</surname>
            <given-names>M T</given-names>
          </name>
          <article-title>Participatory health research: origins and current trends.BGG:</article-title>
          <volume>64</volume>
          <issue>2</issue>
          <fpage>140</fpage>
          <lpage>145</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848774604">
        <label>56.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Baram</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Making clinical trials safer for human subjects</article-title>
          <date>
            <year>2021</year>
          </date>
          <source>Am Journal Law &amp; Med</source>
          <chapter-title>Perspectives on Medical Error: Reactions to the IOM Report</chapter-title>
          <volume>27</volume>
          <fpage>2</fpage>
          <lpage>3</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848772228">
        <label>57.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Pisani</surname>
            <given-names>A R</given-names>
          </name>
          <name>
            <surname>Wyman</surname>
            <given-names>P A</given-names>
          </name>
          <name>
            <surname>Mohr</surname>
            <given-names>D C</given-names>
          </name>
          <name>
            <surname>Perrino</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Human subjects protection and technology in prevention science: selected opportunities and challenges.Prevention</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Science:</source>
          <volume>17</volume>
          <fpage>765</fpage>
          <lpage>778</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1848767116">
        <label>58.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Weaver</surname>
            <given-names>S J</given-names>
          </name>
          <name>
            <surname>Lubomksi</surname>
            <given-names>L H</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>R F</given-names>
          </name>
          <name>
            <surname>Pfoh</surname>
            <given-names>E R</given-names>
          </name>
          <article-title>Promoting a culture of safety as a patient safety strategy: a systematic review</article-title>
          <date>
            <year>2013</year>
          </date>
          <source>Ann Intern Med: Mar 5;158(5 Pt</source>
          <volume>2</volume>
          <fpage>369</fpage>
          <lpage>74</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
